[10-(2-ethylhexanoyloxy)-3-methyl-1,2,3,4-tetrahydroanthracen-9-yl] 2-ethylhexanoate
C31H44O4 — CID 153323301
Data last refreshed: (MolForge compound catalog, from PubChem)
About [10-(2-ethylhexanoyloxy)-3-methyl-1,2,3,4-tetrahydroanthracen-9-yl] 2-ethylhexanoate
[10-(2-ethylhexanoyloxy)-3-methyl-1,2,3,4-tetrahydroanthracen-9-yl] 2-ethylhexanoate (PubChem CID 153323301) has the molecular formula C31H44O4 and a molecular weight of 480.69 g/mol. Its IUPAC name is [10-(2-ethylhexanoyloxy)-3-methyl-1,2,3,4-tetrahydroanthracen-9-yl] 2-ethylhexanoate.
Molecular Properties
| Compound Name | [10-(2-ethylhexanoyloxy)-3-methyl-1,2,3,4-tetrahydroanthracen-9-yl] 2-ethylhexanoate |
|---|---|
| PubChem CID | 153323301 |
| Molecular Formula | C31H44O4 |
| Molecular Weight | 480.69 g/mol |
| Exact Mass | 480.32 |
| IUPAC Name | [10-(2-ethylhexanoyloxy)-3-methyl-1,2,3,4-tetrahydroanthracen-9-yl] 2-ethylhexanoate |
| SMILES | CCCCC(CC)C(=O)Oc1c2c(c(OC(=O)C(CC)CCCC)c3ccccc13)CC(C)CC2 |
| InChI | InChI=1S/C31H44O4/c1-6-10-14-22(8-3)30(32)34-28-24-16-12-13-17-25(24)29(27-20-21(5)18-19-26(27)28)35-31(33)23(9-4)15-11-7-2/h12-13,16-17,21-23H,6-11,14-15,18-20H2,1-5H3 |
| InChIKey | YYLYAYRZNTXVFH-UHFFFAOYSA-N |
| XLogP | 8.21 |
| TPSA | 52.60 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 480.69 |
| LogP ≤ 5 | 8.21 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'phenol_ester', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 153323301 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.